Lebanon Plan Commission on Monday night unanimously approved a design plan for Eli Lilly and Co.’s $4.5 billion center for advanced manufacturing and drug development at the LEAP Research and ...
Robert F. Kennedy — a vaccine critic, obesity-drug skeptic and processed-foods hater — has secured his spot as head of the US Department of Health and Human Services after promising to “Make America ...
So far in 2025, the year’s biggest cultural events have served as launchpads for several of the industry's latest cancer ...
Finding stocks with the potential to double in just three years is no easy feat, even in this bull market. Plenty of ...
By capitalizing on its advantages for business of all sizes, Wisconsin is seeing significant growth in legacy and emerging ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
Eli Lilly stock rose Thursday despite lighter-than-expected sales of its weight-loss and diabetes drugs Zepbound and Mounjaro ...
Fourth-quarter corporate earnings season continues, with investors looking forward to fresh reports from notable companies ...
(Reuters) - Business payments firm Corpay reported an 18% jump in its fourth-quarter profit on Wednesday, driven by a strong performance in the corporate and lodging segments as customers ramped up ...
Novo Nordisk closed up 4.5% Wednesday. Shares of obesity drug rival Eli Lilly, meanwhile, rose 1.4%. Speaking to CNBC Wednesday, CEO and President Lars Fruergaard Jørgensen said that the company ...
In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... these developments by accessing 10 Best AI Data Center Stocks and 10 Buzzing AI Stocks According to Goldman ...
In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... Read more about these developments by accessing 10 Best AI Data Center Stocks and 10 Buzzing AI Stocks According ...